Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Cord Blood Bank (SCCBB) is one of the seven licensed cord blood banking operators in China, established in 1999 and based in Chengdu. It provides both public and private cord blood banking services, including the collection, laboratory testing, processing, and long-term cryopreservation of hematopoietic stem cells. The facility operates an 11,000-square-meter laboratory and has stored over 80,000 cord blood units, facilitating hundreds of successful transplants for various hematological and immune disorders. Beyond storage, the organization collaborates with academic institutions like West China Hospital on advanced cell therapies, including cord blood-derived natural killer (NK) cell research. SCCBB serves as a critical biological resource center for Western China, supporting both clinical applications and regenerative medicine research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Cord Blood Bank.